BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1094511)

  • 1. [Results of studies using the indirect immunofluorescence methods (antinuclear factors) in various rheumatic entities].
    Ripoll Gómez M
    Rev Esp Reum Enferm Osteoartic; 1975; 18(1):65-9. PubMed ID: 1094511
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of loose body test and fluorescence procedure in rheumatism].
    Zabel H
    Z Rheumaforsch; 1969; 28(11):454-8. PubMed ID: 4911937
    [No Abstract]   [Full Text] [Related]  

  • 4. How to use... antinuclear antibodies in paediatric rheumatic diseases.
    Weaver LK; Behrens EM
    Arch Dis Child Educ Pract Ed; 2013 Apr; 98(2):64-70. PubMed ID: 23492397
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of rheumatologic diseases. Significance of autoantibodies against nuclear antigens].
    Poralla T; Mayet W; Hermann E; Manns M; Meyer zum Büschenfelde KH
    Fortschr Med; 1988 Dec; 106(36):726-9. PubMed ID: 3069672
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of circulating anticellular antibodies by indirect immunofluorescence on HEp-2 cell substrates: study of the clinical value of rare fluorescence patterns].
    Haberhauer G; Bröll H
    Z Gesamte Inn Med; 1988 Jul; 43(14):377-80. PubMed ID: 3064447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 9. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?
    Volkmann ER; Taylor M; Ben-Artzi A
    South Med J; 2012 Feb; 105(2):100-4. PubMed ID: 22267099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory diagnosis of systemic rheumatic disease.
    Maehara KT
    Am J Med Technol; 1983 Jul; 49(7):477-81. PubMed ID: 6194686
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of tests for antinuclear antibodies (ANA) in rheumatic diseases.
    Nakamura RN; Tan EM
    West J Med; 1978 Jan; 128(1):51-2. PubMed ID: 415436
    [No Abstract]   [Full Text] [Related]  

  • 12. New studies on rheumatic diseases.
    Tan EW
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():11-28. PubMed ID: 384397
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of antinuclear antibodies by immunoblotting from microgels. Sensitivity of the technic].
    de Keyser F; Verbruggen G; Veys EM; Nimmegeers J; Schatteman L; Goethals K
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):45-6. PubMed ID: 2181609
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methods for determining antinuclear antibodies and their clinical significance].
    Aeschlimann A; Meyer O; Kahn MF; Müller W
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1701-12. PubMed ID: 2694362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The meaning of antinuclear antibodies and of the ASL O titer in rheumatic diseases (author's transl)].
    Zirm M
    Klin Monbl Augenheilkd; 1979 Jan; 174(1):82-7. PubMed ID: 311873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatic disease in childhood. Clinical and pathogenetic notes].
    Vaccaro R; Ramenghi M
    Recenti Prog Med; 1971 Jun; 50(6):538-53. PubMed ID: 4944548
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests.
    Kavanaugh AF; Solomon DH;
    Arthritis Rheum; 2002 Oct; 47(5):546-55. PubMed ID: 12382306
    [No Abstract]   [Full Text] [Related]  

  • 18. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting.
    Oyaert M; Bossuyt X; Ravelingien I; Van Hoovels L
    Clin Chem Lab Med; 2016 Feb; 54(2):e63-6. PubMed ID: 26562037
    [No Abstract]   [Full Text] [Related]  

  • 19. The antinuclear antibody test. When is a positive result clinically relevant?
    Thomas C; Robinson JA
    Postgrad Med; 1993 Aug; 94(2):55-8, 63, 66. PubMed ID: 8341626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear antibody titer and antibodies to extractable nuclear antigens.
    Bossuyt X; Hendrickx A; Frans J
    Arthritis Rheum; 2005 Dec; 53(6):987-8. PubMed ID: 16342092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.